{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:51:39Z","timestamp":1789656699849,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,4,18]]},"DOI":"10.1038\/s41388-026-03714-y","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:31:23Z","timestamp":1773509483000},"page":"1260-1274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LINC-AC092535.5 regulates MICAL2 mRNA level to inhibit p53-mediated ferroptosis in nasopharyngeal carcinoma"],"prefix":"10.1038","volume":"45","author":[{"given":"Siyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiou","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0246-9622","authenticated-orcid":false,"given":"Qicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"3714_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3714_CR2","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1634\/theoncologist.2017-0577","volume":"24","author":"L Chen","year":"2019","unstructured":"Chen L, Zhang Y, Lai SZ, Li WF, Hu WH, Sun R, et al. 10-Year results of therapeutic ratio by intensity-modulated radiotherapy versus two-dimensional radiotherapy in patients with nasopharyngeal carcinoma. Oncologist. 2019;24:e38\u2013e45.","journal-title":"Oncologist"},{"key":"3714_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-016-0167-2","volume":"35","author":"YP Mao","year":"2016","unstructured":"Mao YP, Tang LL, Chen L, Sun Y, Qi ZY, Zhou GQ, et al. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy. Chin J Cancer. 2016;35:103.","journal-title":"Chin J Cancer"},{"key":"3714_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","volume":"16","author":"P Blanchard","year":"2015","unstructured":"Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015;16:645\u201355.","journal-title":"Lancet Oncol"},{"key":"3714_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01999-9","volume":"23","author":"J Diao","year":"2024","unstructured":"Diao J, Jia Y, Dai E, Liu J, Kang R, Tang D, et al. Ferroptotic therapy in cancer: benefits, side effects, and risks. Mol Cancer. 2024;23:89.","journal-title":"Mol Cancer"},{"key":"3714_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"3714_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"3714_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34.","journal-title":"J Hematol Oncol"},{"key":"3714_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23:369\u201379.","journal-title":"Cell Death Differ"},{"key":"3714_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"J Guo","year":"2018","unstructured":"Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res Treat. 2018;50:445\u201360.","journal-title":"Cancer Res Treat"},{"key":"3714_CR11","doi-asserted-by":"publisher","first-page":"e0182921","DOI":"10.1371\/journal.pone.0182921","volume":"12","author":"S Ma","year":"2017","unstructured":"Ma S, Dielschneider RF, Henson ES, Xiao W, Choquette TR, Blankstein AR, et al. Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells. PLoS One. 2017;12:e0182921.","journal-title":"PLoS One"},{"key":"3714_CR12","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1111\/cas.16249","volume":"115","author":"Z Xue","year":"2024","unstructured":"Xue Z, Xie H, Shan Y, Zhang L, Cheng L, Chen W, et al. NAT10 inhibition promotes ac4C-dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma. Cancer Sci. 2024;115:3256\u201372.","journal-title":"Cancer Sci"},{"key":"3714_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.568868","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang Y, Min P, Qi C, Zhao S, Yu M, Zhang Y, et al. MICAL2 facilitates gastric cancer cell migration via MRTF-A-mediated CDC42 activation. Front Mol Biosci. 2021;8:568868.","journal-title":"Front Mol Biosci"},{"key":"3714_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9955717","volume":"2021","author":"C Qi","year":"2021","unstructured":"Qi C, Min P, Wang Q, Wang Y, Song Y, Zhang Y, et al. MICAL2 contributes to gastric cancer cell proliferation by promoting YAP dephosphorylation and nuclear translocation. Oxid Med Cell Longev. 2021;2021:9955717.","journal-title":"Oxid Med Cell Longev"},{"key":"3714_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.7150\/jca.22355","volume":"9","author":"Y Cai","year":"2018","unstructured":"Cai Y, Lu J, Tang F. Overexpression of MICAL2, a novel tumor-promoting factor, accelerates tumor progression through regulating cell proliferation and EMT. J Cancer. 2018;9:521\u20137.","journal-title":"J Cancer"},{"key":"3714_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00952-x","volume":"20","author":"Q Wang","year":"2022","unstructured":"Wang Q, Qi C, Min P, Wang Y, Ye F, Xia T, et al. MICAL2 contributes to gastric cancer cell migration via Cdc42-dependent activation of E-cadherin\/beta-catenin signaling pathway. Cell Commun Signal. 2022;20:136.","journal-title":"Cell Commun Signal"},{"key":"3714_CR17","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1021\/bi4008462","volume":"52","author":"CA McDonald","year":"2013","unstructured":"McDonald CA, Liu YY, Palfey BA. Actin stimulates reduction of the MICAL-2 monooxygenase domain. Biochemistry. 2013;52:6076\u201384.","journal-title":"Biochemistry"},{"key":"3714_CR18","doi-asserted-by":"crossref","unstructured":"Wu M, Harafuji N, O\u2019Connor AK, Caldovic L, Guay-Woodford LM. Transcription factor Ap2b regulates the mouse autosomal recessive polycystic kidney disease genes, Pkhd1 and Cys1. Front Mol Biosci. 2023;9:946344.","DOI":"10.3389\/fmolb.2022.946344"},{"key":"3714_CR19","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.cmet.2023.06.014","volume":"35","author":"X Yang","year":"2023","unstructured":"Yang X, Wang Z, Zandkarimi F, Liu Y, Duan S, Li Z, et al. Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell metabolism. 2023;35:1474.","journal-title":"Cell metabolism"},{"key":"3714_CR20","first-page":"173","volume":"17","author":"V Yee-Lin","year":"2017","unstructured":"Yee-Lin V, Pooi-Fong W, Soo-Beng AK. Nutlin-3, A P53-Mdm2 antagonist for nasopharyngeal carcinoma treatment. Mini Rev Med Chem. 2017;17:173\u201383.","journal-title":"Mini Rev Med Chem"},{"key":"3714_CR21","doi-asserted-by":"crossref","unstructured":"Das AT, Tenenbaum L, Berkhout B. Tet-on systems for doxycycline-inducible gene expression. Curr Gene Ther. 2016;16:156\u2013167.","DOI":"10.2174\/1566523216666160524144041"},{"key":"3714_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1089\/cell.2023.0074","volume":"25","author":"MM Karg","year":"2023","unstructured":"Karg MM, Lu YR, Refaian N, Cameron J, Hoffmann E, Hoppe C, et al. Sustained vision recovery by OSK gene therapy in a mouse model of glaucoma. Cell Reprogramm. 2023;25:288\u201399.","journal-title":"Cell Reprogramm"},{"key":"3714_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.exphem.2023.06.002","volume":"124","author":"J Artus","year":"2023","unstructured":"Artus J, Zenych A, Simanic I, Desterke C, Clay D, Sa\u00efm S, et al. BCR-ABL promotes hematopoietic stem and progenitor cell formation in embryonic stem cells. Exp Hematol. 2023;124:22\u201335.e23.","journal-title":"Exp Hematol"},{"key":"3714_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393\u2013407.","journal-title":"Cell"},{"key":"3714_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904\u201314.","journal-title":"Mol Cell"},{"key":"3714_CR26","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1158\/0008-5472.CAN-19-0799","volume":"79","author":"ZQ Zheng","year":"2019","unstructured":"Zheng ZQ, Li ZX, Zhou GQ, Lin L, Zhang LL, Lv JW, et al. Long Noncoding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p\/miR-1275 and upregulate ITGB3. Cancer Res. 2019;79:4612\u201326.","journal-title":"Cancer Res"},{"key":"3714_CR27","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/nnano.2016.168","volume":"11","author":"S Zanganeh","year":"2016","unstructured":"Zanganeh S, Hutter G, Spitler R, Lenkov O, Mahmoudi M, Shaw A, et al. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol. 2016;11:986\u201394.","journal-title":"Nat Nanotechnol"},{"key":"3714_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nnano.2016.199","volume":"11","author":"A Tarangelo","year":"2016","unstructured":"Tarangelo A, Dixon SJ. Nanomedicine: an iron age for cancer therapy. Nat Nanotechnol. 2016;11:921\u20132.","journal-title":"Nat Nanotechnol"},{"key":"3714_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u201390.","journal-title":"N Engl J Med"},{"key":"3714_CR30","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.2005.01.3441","volume":"24","author":"GK Abou-Alfa","year":"2006","unstructured":"Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2006;24:4293\u20134300.","journal-title":"J Clin Oncol"},{"key":"3714_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1200\/JCO.2008.18.9670","volume":"27","author":"JJ Pan","year":"2009","unstructured":"Pan JJ, Zhang SW, Chen CB, Xiao SW, Sun Y, Liu CQ, et al. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma. J Clin Oncol. 2009;27:799\u2013804.","journal-title":"J Clin Oncol"},{"key":"3714_CR32","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/cam4.2056","volume":"8","author":"X Nie","year":"2019","unstructured":"Nie X, Guo E, Wu C, Liu D, Sun W, Zhang L, et al. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM\/Chk2\/p53 pathway. Cancer Med. 2019;8:1779\u201392.","journal-title":"Cancer Med"},{"key":"3714_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-3574-6","volume":"5","author":"C Yuan","year":"2016","unstructured":"Yuan C, Xu XH, Chen Z. Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis. Springerplus. 2016;5:1885.","journal-title":"Springerplus"},{"key":"3714_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.551318","volume":"11","author":"S Ma","year":"2020","unstructured":"Ma S, Sun L, Wu W, Wu J, Sun Z, Ren J. USP22 protects against myocardial ischemia-reperfusion injury via the SIRT1-p53\/SLC7A11-dependent inhibition of ferroptosis-induced cardiomyocyte death. Front Physiol. 2020;11:551318.","journal-title":"Front Physiol"},{"key":"3714_CR35","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.7150\/thno.28228","volume":"8","author":"J Lu","year":"2018","unstructured":"Lu J, Li Y, Wu Y, Zhou S, Duan C, Dong Z, et al. MICAL2 mediates p53 ubiquitin degradation through oxidating p53 methionine 40 and 160 and promotes colorectal cancer malignance. Theranostics. 2018;8:5289\u2013306.","journal-title":"Theranostics"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03714-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03714-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03714-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T22:02:08Z","timestamp":1774821728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03714-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":35,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,4,18]]}},"alternative-id":["3714"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03714-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}